The New Zealand Liver Transplant Unit, Auckland City Hospital, Private Bag 92-024, Auckland, New Zealand.
Antiviral Res. 2012 Nov;96(2):148-57. doi: 10.1016/j.antiviral.2012.08.007. Epub 2012 Aug 31.
Identification of the full repertoire of hepatitis B virus (HBV) peptides that are presented to CD8+ T cells by common HLA class I alleles will be useful for designing immunotherapies for chronic hepatitis B. One hundred and seventy five cloned sequences containing the pre-S/S and P open reading frames (ORF) of the HBV were obtained from serum HBV-DNA of HBeAg-positive (n=4) and HBeAg-negative (inactive healthy carriers (IHC), n=16) Tongan subjects with an inactive chronic HBV infection. In addition, 34 and 32 sequences were obtained 5.2±1.4 (mean±SD) years apart from eight subjects. PAML was used to identify codons in the pre-S/S and P ORFs that were under positive selection pressure (ω>1). The number of non-synonymous substitutions in these codons was compared in IHC who were homozygous for either HLA-B∗4001 (n=9) or HLA-B5602 (n=7), and who were either positive (n=6) or negative (n=10) for HLA-A02. 34 codons in the pre-S/S and 11 codons in the P ORFs were under positive selection pressure. There was a higher number of non-synonymous substitutions in these codons in HBeAg-negative versus HBeAg-positive subjects in the P (p=0.02) but not the pre-S/S (p=0.64) ORF. There was no association between any HLA class I allele and non-synonymous substitutions in these codons. There was no increase in positive selection pressure on the pre-S/S and P ORFs with time. In conclusion, we could not find HLA class I-restricted selection pressure on any pre-S/S or P ORF amino acid; raising the possibility that peptide-based immunotherapies for chronic hepatitis B may not require peptides from these ORFs.
鉴定乙型肝炎病毒 (HBV) 肽与常见 HLA Ⅰ类等位基因结合并呈递给 CD8+ T 细胞的全部 repertoire 将有助于设计慢性乙型肝炎的免疫疗法。从 HBeAg 阳性(n=4)和 HBeAg 阴性(非活动健康携带者(IHC),n=16)的 Tongan 慢性 HBV 感染者的血清 HBV-DNA 中获得了包含 HBV 前 S/S 和 P 开放阅读框 (ORF) 的 175 个克隆序列。此外,从 8 名受试者中获得了相隔 5.2±1.4(平均值±SD)年的 34 个和 32 个序列。使用 PAML 识别前 S/S 和 P ORF 中的密码子,这些密码子受到正选择压力(ω>1)。在 HLA-B4001(n=9)或 HLA-B5602(n=7)纯合且 HLA-A*02 阳性(n=6)或阴性(n=10)的 IHC 中比较这些密码子中的非同义替换数。前 S/S 中有 34 个密码子和 P ORF 中有 11 个密码子受到正选择压力。在 P 中,HBeAg 阴性相对于 HBeAg 阳性的受试者的这些密码子中的非同义替换数更高(p=0.02),但在前 S/S ORF 中没有(p=0.64)。任何 HLA Ⅰ类等位基因与这些密码子中的非同义替换均无关联。随着时间的推移,前 S/S 和 P ORFs 上的正选择压力没有增加。总之,我们没有发现任何前 S/S 或 P ORF 氨基酸上的 HLA Ⅰ类限制选择压力,这增加了基于肽的慢性乙型肝炎免疫疗法可能不需要这些 ORF 肽的可能性。